Factors Influencing Clinically Meaningful Recanalization after IV-rtPA in Acute Ischemic Stroke

References

1. 1.↵
   1. del Zoppo GJ,
   2. Higashida RT,
   3. Furlan AJ,
   4. et al

   . PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4–11

   Abstract/FREE Full Text
2. 2.↵
   1. Furlan A,
   2. Higashida R,
   3. Wechsler L,
   4. et al

   . Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003–11

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Shi ZS,
   2. Loh Y,
   3. Walker G,
   4. et al

   . Clinical outcomes in middle cerebral artery trunk occlusions versus secondary division occlusions after mechanical thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and multi MERCI trials. Stroke 2010;41:953–60

   Abstract/FREE Full Text
4. 4.↵
   1. Smith WS

   . Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177–82

   Abstract/FREE Full Text
5. 5.↵
   1. Menon BK,
   2. Hill MD,
   3. Eesa M,
   4. et al

   . Initial experience with the Penumbra stroke system for recanalization of large vessel occlusions in acute ischemic stroke. Neuroradiology 2010;53:261–66

   PubMed
6. 6.↵
   1. Smith WS,
   2. Sung G,
   3. Saver J,
   4. et al

   . Mechanical thrombectomy for acute ischemic stroke: final results of the multi MERCI trial. Stroke 2008;39:1205–12

   Abstract/FREE Full Text
7. 7.↵
   1. Hussein HM,
   2. Georgiadis AL,
   3. Vazquez G,
   4. et al

   . Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol 2010;31:454–58

   Abstract/FREE Full Text
8. 8.↵
   IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II study. Stroke 2007;38:2127–35

   Abstract/FREE Full Text
9. 9.↵
   1. Singer OC,
   2. Berkefeld J,
   3. Lorenz MW,
   4. et al

   . Risk of symptomatic intracerebral hemorrhage in patients treated with intra-arterial thrombolysis. Cerebrovasc Dis 2009;27:368–74

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Kase CS,
    2. Furlan AJ,
    3. Wechsler LR,
    4. et al

    . Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603–10

    CrossRef
11. 11.↵
    1. Cloft HJ

    . Death and destruction in the intra-arterial battle with acute ischemic stroke. AJNR Am J Neuroradiol 2011;32:1769–70

    FREE Full Text
12. 12.↵
    1. von Kummer R,
    2. Holle R,
    3. Rosin L,
    4. et al

    . Does arterial recanalization improve outcome in carotid territory stroke? Stroke 1995;26:581–87

    Abstract/FREE Full Text
13. 13.↵
    1. Marks MP,
    2. Olivot JM,
    3. Kemp S,
    4. et al

    . Patients with acute stroke treated with intravenous tPA 3–6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Radiology 2008;249:614–23

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Khatri P,
    2. Abruzzo T,
    3. Yeatts SD,
    4. et al

    . Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066–72

    CrossRef
15. 15.↵
    1. Zaidat OO,
    2. Suarez JI,
    3. Santillan C,
    4. et al

    . Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 2002;33:1821–26

    Abstract/FREE Full Text
16. 16.↵
    1. Alexandrov AV

    . Current and future recanalization strategies for acute ischemic stroke. J Intern Med 2010;267:209–19

    CrossRefPubMed
17. 17.↵
    1. Puetz V,
    2. Dzialowski I,
    3. Hill MD,
    4. et al

    . Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 2008;3:230–36

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Tan IY,
    2. Demchuk AM,
    3. Hopyan J,
    4. et al

    . CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol 2009;30:525–31

    Abstract/FREE Full Text
19. 19.↵
    1. Mendonca N,
    2. Rodriguez-Luna D,
    3. Rubiera M,
    4. et al

    . Predictors of tissue-type plasminogen activator nonresponders according to location of vessel occlusion. Stroke 2011;43:417–21

    PubMed
20. 20.↵
    1. Hacke W,
    2. Kaste M,
    3. Fieschi C,
    4. et al

    . Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017–25

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Adams HP Jr.,
    2. Leclerc JR,
    3. Bluhmki E,
    4. et al

    . Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc Dis 2004;18:124–29

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Wagenmakers EJ,
    2. Farrell S

    . AIC model selection using Akaike weights. Psychon Bull Rev 2004;11:192–96

    CrossRefPubMedWeb of Science
23. 23.↵
    The National Institute of Neurological Disorders and Stroke Rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–87

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Adams HP Jr.,
    2. del Zoppo G,
    3. Alberts MJ,
    4. et al

    . Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research interdisciplinary working groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655–711

    Abstract/FREE Full Text
25. 25.↵
    1. Barber PA,
    2. Demchuk AM,
    3. Zhang J,
    4. et al

    . Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670–74

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Adams HP Jr.,
    2. Davis PH,
    3. Leira EC,
    4. et al

    . Baseline NIH stroke scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999;53:126–31

    CrossRef
27. 27.↵
    1. Goyal M

    . Poor clinical outcome despite successful arterial recanalization. What went wrong? How can we do better? Neuroradiology 2010;52:341–43

    CrossRefPubMed
28. 28.↵
    1. Maas MB,
    2. Furie KL,
    3. Lev MH,
    4. et al

    . National Institutes of Health Stroke Scale Score is poorly predictive of proximal occlusion in acute cerebral ischemia. Stroke 2009;40:2988–93

    Abstract/FREE Full Text
29. 29.↵
    1. Hacke W,
    2. Furlan AJ,
    3. Al-Rawi Y,
    4. et al

    . Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141–50

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Davis SM,
    2. Donnan GA,
    3. Parsons MW,
    4. et al

    . Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299–309

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Hacke W,
    2. Albers G,
    3. Al-Rawi Y,
    4. et al

    . The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73

    Abstract/FREE Full Text
32. 32.↵
    1. Kimura K,
    2. Iguchi Y,
    3. Shibazaki K,
    4. et al

    . Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients. Eur Neurol 2010;63:331–36

    CrossRefPubMed
33. 33.↵
    1. Saqqur M,
    2. Uchino K,
    3. Demchuk AM,
    4. et al

    . Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948–54

    Abstract/FREE Full Text
34. 34.↵
    1. del Zoppo GJ,
    2. Poeck K,
    3. Pessin MS,
    4. et al

    . Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78–86

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Kucinski T,
    2. Koch C,
    3. Eckert B,
    4. et al

    . Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology 2003;45:11–18

    PubMedWeb of Science
36. 36.↵
    1. Christou I,
    2. Felberg RA,
    3. Demchuk AM,
    4. et al

    . Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging 2002;12:119–23

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Jansen O,
    2. von Kummer R,
    3. Forsting M,
    4. et al

    . Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol 1995;16:1977–86

    Abstract
38. 38.↵
    1. Murphy BD,
    2. Fox AJ,
    3. Lee DH,
    4. et al

    . Identification of penumbra and infarct in acute ischemic stroke using computed tomography perfusion-derived blood flow and blood volume measurements. Stroke 2006;37:1771–77

    Abstract/FREE Full Text
39. 39.↵
    1. Janardhan V,
    2. Qureshi AI

    . Mechanisms of ischemic brain injury. Curr Cardiol Rep 2004;6:117–23

    PubMed
40. 40.↵
    1. Miteff F,
    2. Levi CR,
    3. Bateman GA,
    4. et al

    . The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain 2009;132:2231–38

    Abstract/FREE Full Text
41. 41.↵
    1. Christoforidis GA,
    2. Mohammad Y,
    3. Kehagias D,
    4. et al

    . Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26:1789–97

    Abstract/FREE Full Text